Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Lundbeck, officially known as H. Lundbeck A/S, is a global pharmaceutical company headquartered in Denmark (DK). Founded in 1915, Lundbeck has established itself as a leader in the neuroscience sector, focusing on the treatment of brain disorders such as depression, schizophrenia, and Alzheimer's disease. With a strong presence in Europe, North America, and Asia, the company is dedicated to improving the lives of patients through innovative therapies.
Lundbeck's core products include a range of unique medications that address complex neurological conditions, setting them apart in a competitive market. The company has achieved notable milestones, including the development of several breakthrough treatments that have significantly impacted patient care. Renowned for its commitment to research and development, Lundbeck continues to strengthen its position as a key player in the global pharmaceutical industry.
+60 vs industry average
Lundbeck’s score of 100 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
In 2025, H. Lundbeck A/S reported total greenhouse gas emissions of approximately 160.7 million kg CO2e, comprising 20.3 million kg CO2e from Scope 1, 2.9 million kg CO2e from Scope 2, and 137.5 million kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 42% by 2029 from a 2019 baseline. Additionally, Lundbeck targets a 25% reduction in Scope 3 emissions by 2029, focusing on purchased goods and services, upstream transportation, and business travel.
Long-term goals include a significant reduction of 63% in absolute Scope 1 and 2 emissions by 2034 and a 19% reduction in Scope 3 emissions by the same year. Furthermore, Lundbeck is committed to achieving net-zero emissions across its value chain by 2050, with a target to reduce overall emissions (Scopes 1, 2, and 3) by 90% from 2019 levels by 2050.
Lundbeck's Transition Plan also includes a commitment to utilise 100% renewable electricity for all EU sites by 2025, demonstrating its proactive approach to sustainability. The emissions data and targets are sourced directly from H. Lundbeck A/S, reflecting its commitment to transparency and accountability in addressing climate change.
Access structured emission data, company specific factors and auditable source documents
2029
42% reduction in Scope 2
H. Lundbeck A/S commits to reduce absolute scope 2 GHG emissions 42% by 2029 from a 2019 base year.
2050
90% reduction in scope 3 total
H. Lundbeck A/S commits to reduce absolute scope 3 GHG emissions 90% by 2050 from a 2019 base year.
2029
42% reduction in Scope 1
H. Lundbeck A/S commits to reduce absolute scope 1 GHG emissions 42% by 2029 from a 2019 base year.
See all 5 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


Common questions about Lundbeck’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more